Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas

Although high-dose methotrexate (HD-MTX) is the most effective drug against primary CNS lymphomas (PCNSL), outcome-determining variables related to its administration schedule have not been defined. The impact on toxicity and outcome of the area under the curve (AUC(MTX)), dose intensity (DI(MTX)) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreri, A J M, Guerra, E, Regazzi, M, Pasini, F, Ambrosetti, A, Pivnik, A, Gubkin, A, Calderoni, A, Spina, M, Brandes, A, Ferrarese, F, Rognone, A, Govi, S, Dell'Oro, S, Locatelli, M, Villa, E, Reni, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409565/
https://www.ncbi.nlm.nih.gov/pubmed/14735176
http://dx.doi.org/10.1038/sj.bjc.6601472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409565/
https://www.ncbi.nlm.nih.gov/pubmed/14735176
http://dx.doi.org/10.1038/sj.bjc.6601472

Ejemplares similares